Overview
Rosacea is a chronic inflammatory skin condition causing persistent redness, flushing, visible blood vessels, and sometimes spots on the face, predominantly on the cheeks, nose, chin, and forehead. It follows a relapsing course with flares triggered by various factors. It is not contagious and does not scar, but can significantly affect self-confidence.
How common is it?
Rosacea is more common in women and people with lighter skin, although it can affect darker skin and may be harder to recognise. Symptoms can be more severe in men.
Causes and risk factors
Rosacea involves dysregulation of innate immunity in the skin, vascular reactivity, and abnormal responses to environmental triggers. Demodex mite overpopulation and dysbiosis of the skin microbiome are also implicated.
Common risk factors
- Genetic predisposition and fair skin
- Triggers: alcohol, hot drinks, spicy food, extremes of temperature, sun exposure, exercise, emotional stress, certain skin products
- Demodex folliculorum mite overgrowth
- H. pylori infection (weaker association)
- Abnormal kallikrein 5 and cathelicidin peptide levels in skin causing neurogenic inflammation
Symptoms
- Persistent facial redness, sometimes with warmth, burning or stinging; redness can be less visible on brown or black skin.
- Flushing triggered by specific stimuli
- Visible broken blood vessels (telangiectasia)
- Papules and pustules on the face (resembling acne but without blackheads) — papulopustular type
- Skin thickening and enlargement of the nose (rhinophyma) — phymatous type, predominantly in men
- Eye redness, dryness or irritation can occur. Pain, light sensitivity, blurred vision, or a red/gritty eye needs urgent assessment.
When to see a doctor
Arrange assessment for persistent facial symptoms. Seek urgent medical assessment for eye pain, blurred vision, light sensitivity, or a red or gritty eye; these can signal keratitis and should not wait for a routine dermatology appointment.
Diagnosis
Clinical diagnosis based on characteristic facial distribution and morphology. No specific blood tests or skin biopsies needed in typical cases.
Treatments
Topical treatments
Azelaic acid (15 to 20% gel or cream) and ivermectin 1% cream are first-line topical treatments for papulopustular rosacea, reducing both erythema and lesions. Metronidazole gel is also effective.
Oral antibiotics
Low-dose doxycycline 40mg modified-release (sub-antimicrobial dose) is most evidence-based — anti-inflammatory rather than antibiotic effect. Used for moderate-to-severe papulopustular rosacea. 12-week courses.
Prescription medicines for persistent redness
Brimonidine gel or oxymetazoline cream, where available, can temporarily reduce persistent redness. Use only as prescribed. Brimonidine can cause worsening or rebound redness; stop it and seek advice if this occurs.
Laser and IPL
Pulsed dye laser and intense pulsed light (IPL) reduce persistent erythema and telangiectasia that do not respond to topical treatment. Several sessions needed.
Self-care and lifestyle
- Identify and avoid personal triggers using a diary
- Use a high-SPF (30 to 50) broad-spectrum sunscreen every day
- Use gentle, fragrance-free skincare products
- Apply a green-tinted primer to neutralise redness cosmetically if needed
Prevention
Rosacea cannot reliably be prevented. Sun protection, gentle skincare and avoiding personal triggers can help control flares; they do not guarantee that the condition will stop progressing.
Sources for targeted updates
Updated: 24 October 2026. Targeted corrections to frequency, symptoms, urgent-care guidance, treatment, prevention. This update covers the named sections; a full review of the remaining guide is pending.